Sachem Head Capital Management LP Liva Nova PLC Transaction History

Sachem Head Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$40.84 - $58.14 $1.76 Million - $2.5 Million	-43,000 Reduced 23.24%	142,000 $6.19 Million
Q4 2022 Feb 10, 2023	SELL	$43.88 - $56.16 $59.2 Million - $75.8 Million	-1,350,000 Reduced 87.95%	185,000 $10.3 Million
Q3 2022 Nov 14, 2022	SELL	$48.37 - $66.5 $10.9 Million - $14.9 Million	-224,500 Reduced 12.76%	1,535,000 $77.9 Million
Q1 2022 May 13, 2022	BUY	$71.02 - $86.99 $1.78 Million - $2.17 Million	25,000 Added 1.44%	1,759,500 $144 Million
Q4 2021 Feb 11, 2022	BUY	$76.72 - $92.68 $46.8 Million - $56.5 Million	609,500 Added 54.18%	1,734,500 $152 Million
Q3 2021 Nov 12, 2021	BUY	$76.02 - $88.62 $17.9 Million - $20.8 Million	235,000 Added 26.4%	1,125,000 $89.1 Million
Q2 2021 Aug 13, 2021	BUY	$73.44 - $87.01 $65.4 Million - $77.4 Million	890,000 New	890,000 $74.9 Million

261

52.9M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.5B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Sachem Head Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Sachem Head Capital Management LP with notifications on news.